Stansberry Asset Management’s AbbVie ABBV Stock Holding History

Stansberry Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$363K	Sell	1,668 -236	-12%	-$52.4K	0.04%	129
2025 Q4	$435K	Buy	1,904 +123	+7%	+$28K	0.04%	133
2025 Q3	$412K	Hold	1,781	–	–	0.04%	134
2025 Q2	$331K	Sell	1,781 -49	-3%	-$9.11K	0.04%	134
2025 Q1	$383K	Sell	1,830 -150	-8%	-$29.2K	0.05%	119
2024 Q4	$352K	Buy	+1,980	New	+$364K	0.05%	118
2018 Q2	–	Sell	-22,268	Closed	-$2.11M	–	96
2018 Q1	$2.11M	Buy	+22,268	New	+$2.45M	1.03%	34

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stansberry Asset Management's ABBV Position: Q1 2026 in Review

Stansberry Asset Management reduced its AbbVie (ABBV) stake by 12% in Q1 2026, selling an estimated $52.4K and leaving 1,668 shares worth $363K. The position accounts for 0.04% of the portfolio, ranked #129.

Stansberry Asset Management first reported a position in ABBV in Q1 2018 and has held it in 7 quarters since. The position peaked at $2.11M in Q1 2018. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Stansberry Asset Management held 1,668 shares of AbbVie worth $363K as of Q1 2026.
Stansberry Asset Management sold 236 AbbVie shares in Q1 2026, an estimated $52.4K.
AbbVie made up 0.04% of Stansberry Asset Management's portfolio in Q1 2026, its #129 holding.
Stansberry Asset Management first reported a position in AbbVie in Q1 2018 and has held it in 7 quarters since.
Stansberry Asset Management's AbbVie position peaked at $2.11M in Q1 2018.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Stansberry Asset Management's 13F filing for Q1 2026, filed 15 May 2026.